Editors’ Introduction to the Special Section on Replicability in Psychological Science
Editors’ Introduction to the Special Section on Replicability in Psychological Science
复制标题
心理科学可重复性专题编辑简介
DOI:
--
复制
发表时间:
2012
影响因子:
12.6
通讯作者:
E. Wagenmakers
中科院分区:
文献类型:
--
作者:
H. Pashler;E. Wagenmakers
Is there currently a crisis of confidence in psychological science reflecting an unprecedented level of doubt among practitioners about the reliability of research findings in the field? It would certainly appear that there is. These doubts emerged and grew as a series of unhappy events unfolded in 2011: the Diederik Stapel fraud case (see Stroebe, Postmes, & Spears, 2012, this issue), the publication in a major social psychology journal of an article purporting to show evidence of extrasensory perception (Bem, 2011) followed by widespread public mockery (see Galak, LeBoeuf, Nelson, & Simmons, in press; Wagenmakers, Wetzels, Borsboom, & van der Maas, 2011), reports by Wicherts and colleagues that psychologists are often unwilling or unable to share their published data for reanalysis (Wicherts, Bakker, & Molenaar, 2011; see also Wicherts, Borsboom, Kats, & Molenaar, 2006), and the publication of an important article in Psychological Science showing how easily researchers can, in the absence of any real effects, nonetheless obtain statistically significant differences through various questionable research practices (QRPs) such as exploring multiple dependent variables or covariates and only reporting these when they yield significant results (Simmons, Nelson, & Simonsohn, 2011). For those psychologists who expected that the embarrassments of 2011 would soon recede into memory, 2012 offered instead a quick plunge from bad to worse, with new indications of outright fraud in the field of social cognition (Simonsohn, 2012), an article in Psychological Science showing that many psychologists admit to engaging in at least some of the QRPs examined by Simmons and colleagues (John, Loewenstein, & Prelec, 2012), troubling new meta-analytic evidence suggesting that the QRPs described by Simmons and colleagues may even be leaving telltale signs visible in the distribution of p values in the psychological literature (Masicampo & Lalande, in press; Simonsohn, 2012), and an acrimonious dust-up in science magazines and blogs centered around the problems some investigators were having in replicating well-known results from the field of social cognition (Bower, 2012; Yong, 2012). Although the very public problems experienced by psychology over this 2-year period are embarrassing to those of us working in the field, some have found comfort in the fact that, over the same period, similar concerns have been arising across the scientific landscape (triggered by revelations that will be described shortly). Some of the suspected causes of unreplicability, such as publication bias (the tendency to publish only positive findings) have been discussed for years; in fact, the phrase file-drawer problem was first coined by a distinguished psychologist several decades ago (Rosenthal, 1979). However, many have speculated that these problems have been exacerbated in recent years as academia reaps the harvest of a hypercompetitive academic climate and an incentive scheme that provides rich rewards for overselling one’s work and few rewards at all for caution and circumspection (see Giner-Sorolla, 2012, this issue). Equally disturbing, investigators seem to be replicating each others’ work even less often than they did in the past, again presumably reflecting an incentive scheme gone askew (a point discussed in several articles in this issue, e.g., Makel, Plucker, & Hegarty, 2012). The frequency with which errors appear in the psychological literature is not presently known, but a number of facts suggest it might be disturbingly high. Ioannidis (2005) has shown through simple mathematical modeling that any scientific field that ignores replication can easily come to the miserable state wherein (as the title of his most famous article puts it) “most published research findings are false” (see also Ioannidis, 2012, this issue, and Pashler & Harris, 2012, this issue). Meanwhile, reports emerging from cancer research have made such grim scenarios seem more plausible: In 2012, several large pharmaceutical companies revealed that their efforts to replicate exciting preclinical findings from published academic studies in cancer biology were only rarely verifying the original results (Begley & Ellis, 2012; see also Osherovich, 2011; Prinz, Schlange, & Asadullah, 2011).